Tuesday, August 11, 2026

Samsung’s 176 Million USD Investment in Element Biosciences: What It Means for Precision Medicine in Asia

Samsung Electronics invests $176 million in Element Biosciences, enhancing its position in the precision medicine market with advanced genomic technology.

GM Shifts Buick Envision Production from China to U.S.: What This Means for Jobs and EVs

GM shifts Buick SUV production from China to the U.S. to boost jobs amid tariffs, with plans for more U.S. manufacturing expansion.

Europe Moves to Ease Biosimilar Rules, Boosting Asia’s Biopharma Giants

EMA's new guidelines aim to simplify biosimilar development, boosting Samsung Bioepis and Celltrion in Europe's growing market.

Tag: non-tariff issues

No posts to display

Top News

- Our Sponsors Ad -

Follow us